Finance

Beta
Lists
6833:HKG
Sinco Pharmaceuticals Holdings Ltd
HK$0.17
+0.59%
(+0.0010) 1D
Jun 9, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6833...
Open
HK$0.17
High
HK$0.17
Low
HK$0.17
Mkt. cap
339.44M
Avg. vol.
344.73K
Volume
84.00K
Dividend
0.98%
Quarterly dividend
HK$0.00
Ex-dividend date
May 20, 2024
P/E ratio
8.63
52-wk high
HK$0.28
52-wk low
HK$0.15
EPS
HK$0.02
Shares outstanding
2.03B
No. of employees
261
Open
HK$0.17
High
HK$0.17
Low
HK$0.17
Mkt. cap
339.44M
Avg. vol.
344.73K
Volume
84.00K
Dividend
0.98%
Quarterly dividend
HK$0.00
Ex-dividend date
May 20, 2024
P/E ratio
8.63
52-wk high
HK$0.28
52-wk low
HK$0.15
EPS
HK$0.02
Shares outstanding
2.03B
No. of employees
261
News stories
From sources across the web
About Sinco Pharmaceuticals Holdings Ltd
CEO-
Employees261
Founded2011
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
597.91M
597.91M
444.38M
444.38M
Cost of goods sold
532.56M
532.56M
398.68M
398.68M
Cost of revenue
532.56M
532.56M
398.68M
398.68M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.93M
33.93M
36.22M
36.22M
Operating expense
39.44M
39.44M
34.27M
34.27M
Total operating expenses
572.00M
572.00M
432.95M
432.95M
Operating income
25.91M
25.91M
11.42M
11.42M
Other non operating income
-1.83M
-1.83M
-132.50K
-132.50K
EBT including unusual items
18.28M
18.28M
5.85M
5.85M
EBT excluding unusual items
17.37M
17.37M
6.76M
6.76M
Income tax expense
6.08M
6.08M
620.00K
620.00K
Effective tax rate
33.28%
33.28%
10.60%
10.60%
Other operating expenses
-
-
-
-
Net income
12.19M
12.19M
5.23M
5.23M
Net profit margin
2.04%
2.04%
1.18%
1.18%
Earnings per share
-
-
-
-
Interest and investment income
681.50K
681.50K
1.33M
1.33M
Interest expense
-4.29M
-4.29M
-3.39M
-3.39M
Net interest expenses
-3.61M
-3.61M
-2.06M
-2.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
31.64M
31.64M
15.09M
15.09M
Gain or loss from assets sale
-904.00K
-904.00K
904.00K
904.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more